1. Market Research
  2. > Pharmaceutical
  3. > OTC Market Trends
Global Anti-Fungal Drugs Market, By Drug Class, By Indication, By Infection Type, By Route of Administration, By End User By Distribution Channel, By Region, Competition Forecast & Opportunities, 2026

Global Anti-Fungal Drugs Market, By Drug Class, By Indication, By Infection Type, By Route of Administration, By End User By Distribution Channel, By Region, Competition Forecast & Opportunities, 2026

  • October 2021
  • 114 pages
  • ID: 6156159
  • Format: PDF
  • TechSci Research


Table of Contents

Global Anti-Fungal Drugs Market, By Drug Class (Azoles, Echinocandins, Polyenes, Allylamines, Others), By Indication (Candidiasis, Aspergillosis, Mucormycosis, Dermatophytosis, Others), By Infection Type (Superficial Fungal Infection, Systemic Fungal Infection), By Route of Administration (Topical, Oral, Parenteral, Others), By End User (Homecare, Hospitals, Clinics, Others) By Distribution Channel (Retail Pharmacy, Hospital Pharmacy, Online Pharmacy), By Region, Competition Forecast & Opportunities, 2026

Global anti-fungal drugs market is expected to reach USD28484.69 million by 2026, growing at CAGR of 10.39% over the forecast period. Fungal infections can lead to diseases including fungal pneumonia, candidiasis, mucormycosis, among others and these fungal infections require the dosage of anti-fungal drugs to ensure effective treatment. The increasing prevalence of fungal infections is considered the primary driver for the market growth in the forecast period. The rise in awareness levels among patients regarding the adverse effect of fungal infection on the human body is significantly accelerating the demand for anti-fungal drugs around the world. An increase in government funds and investments to promote research and development activities to formulate anti-fungal drugs is fueling the market growth. An increase in the use of anti-fungal drugs coupled with the rising number of anti-fungal drugs available over-the-counter is expected to boost the market demand. With the surge in popularity of over-the-counter drugs such as ketoconazole, miconazole, econazole, amorolfine, several patients are preferring over-the-counter drugs. The rise in onychomycosis cases, which is a fungal infection affecting fingers and toenails is also considered a major driver responsible for the high demand for anti-fungal drugs.

The global anti-fungal drugs market is segmented into drug class, indication, infection type, route of administration, end-user, distribution channel, regional distribution, and company.Based on drug class, market is further divided into azoles, echinocandins, polyenes, allylamines and others.

The azoles segment is expected to dominate the anti-fungal drugs market in the forecast period owing to their use in treatment of almost all the indications.Based on indication, the market is segmented into candidiasis, aspergillosis, dermatophytosis, mucormycosis, and others.

The candidiasis segment is expected to dominate the market owing to high cases globally associated with the fungal species.

Based on regional analysis, North America is expected to dominate the anti-fungal drugs market for the next five years owing to the presence of major market players in the region.The high prevalence of fungal infections in the region is another crucial factor aiding the market growth.

Well-developed healthcare infrastructure and favorable government healthcare policies are the other significant factors bolstering the market growth.
The major players operating in the global anti-fungal drugs market are Astellas Pharma Inc., GlaxoSmithKline Plc, Bayer AG, Dr. Reddy’s Laboratories Ltd., Gilead Sciences Inc., Janssen Pharmaceuticals Inc. (Johnson & Johnson), Pfizer Inc., Sanofi S.A., Merck & Co., Inc., Glenmark Pharmaceuticals Ltd., Sun Pharmaceuticals Industries Ltd., Teva Pharmaceutical Industries Ltd., Viatris Inc. (Mylan Laboratories Inc.), Cipla Ltd., Zydus Cadila Ltd., Lupin Ltd., Torrent Pharmaceuticals Ltd, Abbott Laboratories Inc., Novartis AG, Galderma SA among others. Major companies are developing advanced technologies and launching new anti-fungal drugs to stay competitive in the market. Other competitive strategies include mergers & acquisitions and new product developments.

Years considered for this report:

Historical Years: 2016-2019
Base Year: 2020
Estimated Year: 2021
Forecast Period: 2022–2026

Objective of the Study:

• To analyze the historical growth in the market size of global anti-fungal drugs market from 2016 to 2020.
• To estimate and forecast the market size of global anti-fungal drugs market from 2021 to 2026 and growth rate until 2026.
• To classify and forecast global anti-fungal drugs market based on drug class, indication, infection type, route of administration, end user, distribution channel, regional distribution, and company.
• To identify dominant region or segment in the global anti-fungal drugs market.
• To identify drivers and challenges for global anti-fungal drugs market.
• To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in global anti-fungal drugs market.
• To identify and analyze the profile of leading players operating in global anti-fungal drugs market.
• To identify key sustainable strategies adopted by market players in global anti-fungal drugs market.
The analyst performed both primary as well as exhaustive secondary research for this study.Initially, the analyst sourced a list of manufacturers across the globe.

Subsequently, the analyst conducted primary research surveys with the identified companies.While interviewing, the respondents were also enquired about their competitors.

Through this technique, the analyst could include the manufacturers who could not be identified due to the limitations of secondary research. The analyst examined the manufacturers, distribution channels and presence of all major players across the globe.
The analyst calculated the market size of global anti-fungal drugs market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. The analyst sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of various segments for getting an appropriate, overall market size.

Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by the analyst.

Key Target Audience:

• Anti-fungal drug manufacturing companies
• Market research and consulting firms
• Government bodies such as regulating authorities and policy makers
• Organizations, forums and alliances related to anti-fungal drugs market
The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as manufacturers, suppliers and partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope:

In this report, global anti-fungal drugs market has been segmented into following categories, in addition to the industry trends which have also been detailed below:
• Global Anti-Fungal Drugs Market, By Drug Class:
o Azoles
o Echinocandins
o Polyenes
o Allylamines
o Others
• Global Anti-Fungal Drugs Market, By Indication:
o Candidiasis
o Aspergillosis
o Mucormycosis
o Dermatophytosis
o Others
• Global Anti-Fungal Drugs Market, By Infection Type:
o Superficial Fungal Infection
o Systemic Fungal Infection
• Global Anti-Fungal Drugs Market, By Route of Administration:
o Topical
o Oral
o Parenteral
o Others
• Global Anti-Fungal Drugs Market, By End-User:
o Homecare
o Hospitals
o Clinics
o Others
• Global Anti-Fungal Drugs Market, By Distribution Channel:
o Retail Pharmacy
o Hospital Pharmacy
o Online Pharmacy
• Global Anti-Fungal Drugs Market, By Region:
o North America
United States
o Europe
United Kingdom
o Asia-Pacific
South Korea
o South America
o Middle East & Africa
South Africa
Saudi Arabia

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global anti-fungal drugs market.

Available Customizations:

With the given market data, we offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.

ReportLinker may already be registered as a supplier with your company. If you want to Order by PO, check with us first and we'll let you know if we are a registered supplier and what the vendor number is. Otherwise, we'll provide you with the necessary information to register ReportLinker as a vendor.

Ahmad helps you find the right report:

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at [email protected] to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - [email protected] or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers

Dermatophytic Onychomycosis Treatment Market Growth Analysis and Insights, 2021: Trends, Market Size, Share Outlook and Opportunities by Type, Application, End Users, Countries and Companies to 2028

  • $ 4580
  • September 2021
  • 135 pages

Dermatophytic Onychomycosis Treatment market is one of the high-growth prospect industries with potential opportunities throughout 2028. The Dermatophytic Onychomycosis Treatment Market growth analysis ...

  • World
  • Antifungal
  • Infectious Disease
  • Industry analysis


Reportlinker.com © Copyright 2021. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on